Antonio Nicolucci

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Venues

Diabetes, obesity & metabolism

Acta diabetologica

Diabetes therapy : research, treatment and education of diabetes and related disorders

JMIR mHealth and uHealth

Center for Outcomes Research and Clinical Epidemiology - CORESEARCH SRL

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for Outcomes Research and Clinical Epidemiology - CORESEARCH SRL Feb 01 2015

Italy

Director

Publications

null null, Raffaella Buzzetti, Riccardo Candido, Katherine Esposito, Andrea Giaccari, Edoardo Mannucci, Antonio Nicolucci, Giuseppina T Russo
Open questions on basal insulin therapy in T2D: a Delphi consensus. Acta diabetologica (2024)
Antonio Nicolucci, Giusi Graziano, Fortunato Lombardo, Ivana Rabbone, Maria Chiara Rossi, Giacomo Vespasiani, Stefano Zucchini, Riccardo Bonfanti, null null
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry. Acta diabetologica 61 (5) (2024)
Vincenzo Atella, Federico Belotti, Matilde Giaccherini, Gerardo Medea, Andrea Piano Mortari, Paolo Sbraccia, Antonio Nicolucci
The interplay between excess weight and hyper-glycemia on NCDs in Italy: results from a cross-sectional study. Acta diabetologica (2024)
Raffaele Napoli, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Riccardo Candido, null null
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study. Diabetes, obesity & metabolism 26 (9) (2024)
Raffaele Napoli, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Riccardo Candido, null null
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study. Diabetes, obesity & metabolism (2024)
Antonio Nicolucci, Giusi Graziano, Fortunato Lombardo, Ivana Rabbone, Maria Chiara Rossi, Giacomo Vespasiani, Stefano Zucchini, Riccardo Bonfanti, null null
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry. Acta diabetologica (2024)
Antonio Nicolucci, Giusi Graziano, Fortunato Lombardo, Ivana Rabbone, Maria Chiara Rossi, Giacomo Vespasiani, Stefano Zucchini, Riccardo Bonfanti, null null
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry. Acta diabetologica 61 (5) (2024)
Antonio Nicolucci, Giusi Graziano, Fortunato Lombardo, Ivana Rabbone, Maria Chiara Rossi, Giacomo Vespasiani, Stefano Zucchini, Riccardo Bonfanti, null null
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry. Acta diabetologica 61 (5) (2024)
Stefano Balducci, Jonida Haxhi, Martina Vitale, Lorenza Mattia, Massimo Sacchetti, Giorgio Orlando, Patrizia Cardelli, Carla Iacobini, Lucilla Bollanti, Francesco Conti, Silvano Zanuso, Antonio Nicolucci, Giuseppe Pugliese, null null
Sustained increase in physical fitness independently predicts improvements in cardiometabolic risk profile in type 2 diabetes. Diabetes/metabolism research and reviews (2023)
Brenda W C Bongaerts, Oliver Kuß, Fabrice Bonnet, Hungta Chen, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Niklas Hammar, Li-Nong Ji, Kamlesh Khunti F MedSci, Jesus Medina, Antonio Nicolucci, Marina V Shestakova, Hirotaka Watada, Wolfgang Rathmann
HbA 1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study. Diabetes, obesity & metabolism (2023)
Andrea Iannone, Patrizia Natale, Suetonia C Palmer, Antonio Nicolucci, Maria Rendina, Francesco Giorgino, Luigi Laviola, Alfredo Di Leo, Giovanni F M Strippoli
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Laura D'Erasmo, Michele Di Martino, Thomas Neufeld, Tyler J Fraum, Chul Joo Kang, Kendall H Burks, Alessia Di Costanzo, Ilenia Minicocci, Simone Bini, Marianna Maranghi, Giovanni Pigna, Giancarlo Labbadia, Jie Zheng, Davide Fierro, Anna Montali, Fabrizio Ceci, Carlo Catalano, Nicholas O Davidson, Giuseppe Lucisano, Antonio Nicolucci, Marcello Arca, Nathan O Stitziel
ANGPTL3 Deficiency and Risk of Hepatic Steatosis. Circulation (2023)
Bernard H Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Gabriela L Saraiva, Jesús Medina, Antonio Nicolucci, Marina V Shestakova, Iichiro Shimomura, Filip Surmont, Fengming Tang, Jiten Vora, Hirotaka Watada, Kamlesh Khunti F MedSci, null null
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study. Diabetes, obesity & metabolism (2022)
Vittal Hejjaji, Juan J Gorgojo-Martinez, Fengming Tang, Julia Blanco Garnelo, Andrew Cooper, Jesús Medina, Miren Sequera Mutiozabal, Kamlesh Khunti F MedSci, Antonio Nicolucci, Marina V Shestakova, Li-Nong Ji, Marília Brito Gomes, Hirotaka Watada, Jiten Vora, Ali O Malik, Mikhail Kosiborod, Suzanne V Arnold
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study. Diabetes, obesity & metabolism 24 (9) (2022)
Antonio Nicolucci, Claudio Maffeis
The adolescent with obesity: what perspectives for treatment? Italian journal of pediatrics 48 (1) (2022)
Antonio Nicolucci, Luca Leonardi
Compatibility of PiC Insupen Needles with a Broad Range of Pens for the Injection of Subcutaneously Administered Drugs for Diabetes. Medical devices (Auckland, N.Z.) 15 (2022)
Gian Paolo Fadini, Raffaella Buzzetti, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Domenico Cucinotta, null null
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY). Acta diabetologica 59 (10) (2022)
Heeyoung Hwang, Luca Leonardi, Antonio Nicolucci
Accuracy of the Standard GlucoNavii Mentor in Blood Glucose Monitoring According to International Organization for Standardization 15197:2013 Criteria. JMIR diabetes 7 (2) (2022)
Riccardo Candido, Monica Modugno, Monica Larosa, Maria Chiara Rossi, Antonio Nicolucci, Enrico Gabellieri, null null
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Basilio Pintaudi, Alessia Scatena, Gabriella Piscitelli, Vera Frison, Salvatore Corrao, Valeria Manicardi, Giusi Graziano, Maria Chiara Rossi, Marco Gallo, Domenico Mannino, Paolo Di Bartolo, Antonio Nicolucci
Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study. Cardiovascular diabetology 20 (1) (2021)
Lucrezia Ferrario, Fabrizio Schettini, Angelo Avogaro, Chiara Bellia, Federico Bertuzzi, Graziella Bonetti, Antonio Ceriello, Marcello Ciaccio, Massimiliano Corsi Romanelli, Elena Dozio, Luca Falqui, Angela Girelli, Antonio Nicolucci, Gianluca Perseghin, Maria Rosaria Capobianchi, Umberto Valentini, Martina Zaninotto, Silvana Castaldi, Emanuela Foglia
Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation. ClinicoEconomics and outcomes research : CEOR 13 (2021)
Kamlesh Khunti F MedSci, Bernard Charbonnel, Andrew Cooper, Marília Brito Gomes, Li-Nong Ji, Paul Leigh, Antonio Nicolucci, Wolfgang Rathmann, Marina V Shestakova, Afrah Siddiqui, Fengming Tang, Hirotaka Watada, Hungta Chen, null null
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study. Diabetes, obesity & metabolism 23 (8) (2021)
Kamlesh Khunti F MedSci, Bernard Charbonnel, Hungta Chen, David Z Cherney, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Niklas Hammar, Hiddo J Lambers Heerspink, Li-Nong Ji, Jesús Medina, Antonio Nicolucci, Larissa Ramirez, Wolfgang Rathmann, Marina V Shestakova, Iichiro Shimomura, Fengming Tang, Hirotaka Watada, Mikhail Kosiborod, null null
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study. Diabetes, obesity & metabolism 23 (8) (2021)
Søren Eik Skovlund, Antonio Nicolucci, Nina Charlotte Balk-Møller, Dorthe B Berthelsen, Charlotte Glümer, Hans Perrild, Pernille Kjær, Lise Mellergaard Noergaard, Lise Havbæk Troelsen, Anna Pietraszek, Danielle M Hessler, Sherrie H Kaplan, Niels Ejskjær
Perceived Benefits, Barriers, and Facilitators of a Digital Patient-Reported Outcomes Tool for Routine Diabetes Care: Protocol for a National, Multicenter, Mixed Methods Implementation Study. JMIR research protocols 10 (9) (2021)
Antonio Nicolucci, Maria Chiara Rossi, Massimiliano Petrelli
Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study. Journal of diabetes research 2021 (2021)
Rossella Messina, Marica Iommi, Paola Rucci, Chiara Reno, Maria Pia Fantini, Carlotta Lunghi, Mattia Altini, Francesca Bravi, Simona Rosa, Antonio Nicolucci, Paolo Di Bartolo
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study. Acta diabetologica (2021)
Antonio Nicolucci, Jonida Haxhi, Valeria D'Errico, Massimo Sacchetti, Giorgio Orlando, Patrizia Cardelli, Martina Vitale, Lucilla Bollanti, Francesco Conti, Silvano Zanuso, Giuseppe Lucisano, Stefano Balducci, Giuseppe Pugliese, null null
Effect of a Behavioural Intervention for Adoption and Maintenance of a Physically Active Lifestyle on Psychological Well-Being and Quality of Life in Patients with Type 2 Diabetes: The IDES_2 Randomized Clinical Trial. Sports medicine (Auckland, N.Z.) (2021)
Marta Baviera, Stefano Genovese, Vito Lepore, Pierluca Colacioppo, Fabio Robusto, Mauro Tettamanti, Antonio D'Ettorre, Fausto Avanzini, Ida Fortino, Antonio Nicolucci, Maria C Roncaglioni, Francesco Giorgino
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts. Diabetes, obesity & metabolism 23 (7) (2021)
Luigi Laviola, Francesca Porcellati, Daniela Bruttomesso, Monica Larosa, Maria Chiara Rossi, Antonio Nicolucci, null null
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (2) (2020)
Mauro Ragonese, Monica Larosa, Stefania Angotti, Stefania Annese, Laura Cruciani, Michela Dainelli, Giuseppe Lucisano, Giuseppe Prosperini, Michele Sacco, Enrica Salomone, Caterina Saponara, Roberta Semprini, Maria Chiara Rossi, Antonio Nicolucci
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (10) (2020)
Antonio Nicolucci, Riccardo Candido, Domenico Cucinotta, Giusi Graziano, Alberto Rocca, Maria C Rossi, Franco Tuccinardi, Valeria Manicardi
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice. Advances in therapy 36 (10) (2019)
Antonio Nicolucci, Bernard Charbonnel, Marília Brito Gomes, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Marina V Shestakova, Iichiro Shimomura, Hirotaka Watada, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Stuart Pocock
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes, obesity & metabolism 21 (11) (2019)
Valentino Cherubini, Ivana Rabbone, Fortunato Lombardo, Gilberto Mossetto, Marco Orsini Federici, Antonio Nicolucci
Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic review. Pediatric diabetes 20 (6) (2019)
Kamlesh Khunti F MedSci, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Marília Brito Gomes, Niklas Hammar, Linong Ji, Mikhail Kosiborod, Stuart Pocock, Marina V Shestakova, Iichiro Shimomura, Fengming Tang, Hirotaka Watada, Antonio Nicolucci, null null
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme. Diabetes, obesity & metabolism 22 (1) (2019)
Emanuela Orsi, Anna Solini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Gabriella Gruden, Susanna Morano, Antonio Nicolucci, Giuseppe Penno, Giuseppe Pugliese, null null
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes. Diabetes, obesity & metabolism 20 (8) (2018)
Yuan Wu, Xun Yao, Giacomo Vespasiani, Antonio Nicolucci, Yajie Dong, Joey Sum-Wing Kwong, Ling Li, Xin Sun, Haoming Tian, Sheyu Li
Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR mHealth and uHealth 6 (1) (2018)
Annunziata Lapolla, Cesare Berra, Massimo Boemi, Antonio Carlo Bossi, Riccardo Candido, Graziano Di Cianni, Simona Frontoni, Stefano Genovese, Paola Ponzani, Vincenzo Provenzano, Giuseppina T Russo, Luigi Sciangula, Natalino Simioni, Cristiano Bette, Antonio Nicolucci, null null
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. Advances in therapy 35 (2) (2017)
Yuan Wu, Xun Yao, Giacomo Vespasiani, Antonio Nicolucci, Yajie Dong, Joey Sum-Wing Kwong, Ling Li, Xin Sun, Haoming Tian, Sheyu Li
Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR mHealth and uHealth 5 (3) (2017)

Antonio Nicolucci.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Nicolucci